Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Genentech ends dosing in phase III study of tominersen for Huntington's disease

March 23, 2021

CaaMTech patents new ammonium tryptamines for pain

March 23, 2021

Novel C3 conditional knockout mouse model of AD

March 22, 2021

Updated phase Ib data presented for PF-06939926 in boys with DMD

March 22, 2021

FDA approves Ponvory as oral treatment for adults with relapsing multiple sclerosis

March 22, 2021

Reprogrammed cells repair vasculature, brains after stroke

March 22, 2021

Dopamine plays role in pain perception sex differences

March 22, 2021

Sarepta Therapeutics presents results for SRP-9001 gene therapy in nonhuman primates

March 19, 2021

Phase II interim analysis data presented for apitegromab in patients with SMA

March 19, 2021

Characterization of a new mouse model of Parkinson's disease

March 19, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 20, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...